Showing results (91-100 of 248) with videos related to
Sort By:
Pageof 25
Leukemia & Lymphoma|June 7, 2019
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practiceFederica Cocito, Silvia Mangiacavalli, Virginia Valeria Ferretti, et al.British Journal of Haematology|June 17, 2004
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infectionAchille Ambrosetti, Roberta Zanotti, Cristian Pattaro, et al.Blood|December 24, 2005
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disordersFrancesco Passamonti, Elisa Rumi, Daniela Pietra, et al.Leukemia & Lymphoma|September 18, 2015
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphomaStefano Luminari, Maria Goldaniga, Marina Cesaretti, et al.Blood|January 23, 2014
B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteinsPatrick P Ng, Chiung-Chi Kuo, Stanley Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2007
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipationElisa Rumi, Francesco Passamonti, Matteo G Della Porta, et al.Pharmaceutics|June 28, 2023
Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid LeukemiaSimona De Gregori, Eleonora Gelli, Mara Capone, et al.Clinical Nutrition (Edinburgh, Scotland)|July 9, 2020
Validation of a new prognostic body composition parameter in cancer patientsEmanuele Cereda, Marilisa Caraccia, Catherine Klersy, et al.British Journal of Haematology|February 23, 2019
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)Chiara Rusconi, Antonella Anastasia, Annalisa Chiarenza, et al.American Journal of Hematology|December 4, 2024
Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUSSilvia Mangiacavalli, Paolo Milani, Claudio Salvatore Cartia, et al.Pageof 25